Catheter-based renal sympathetic nerve denervation on hypertension management outcomes.
World J Radiol
; 14(7): 238-248, 2022 Jul 28.
Article
en En
| MEDLINE
| ID: mdl-36160631
ABSTRACT
BACKGROUND:
Renal sympathetic denervation (RSD) provides a minimally invasive interventional treatment modality for patients with resistant hypertension. However, the post-operative outcomes remain a key area of investigation since its earliest clinical trials.AIM:
To evaluate patient outcomes after RSD intervention among peer-reviewed patient cases.METHODS:
A systematic review of literature on MEDLINE, Google Scholar, and the Cochrane Database of Systematic Reviews for RSD case studies to assess post-operative hypertension readings and medical management.RESULTS:
Among 51 RSD cases, the post-operative RSD patients report an apparent reduction with a mean number of 3.1 antihypertensive medications. The mean systolic arterial blood pressure 1 year following RSD was 136.0 mmHg (95%CI 118.7-153.3).CONCLUSION:
The apparent improvements in office systolic blood pressure after 12 month post-operative RSD can support the therapeutic potential of this intervention for blood pressure reduction. Additional studies which utilized a uniform methodology for blood pressure measurement can further support the findings of this systematic review.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Systematic_reviews
Idioma:
En
Revista:
World J Radiol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos